Sorry! This product is no longer available.

Product Details:
|
Purity: | 99%min | Application: | Pharmaceutical Intermediates |
---|---|---|---|
Type: | Syntheses Material Intermediates | Appearance: | White Powder |
Cas No.: | 171596-29-5 | Product Name: | Tadafil |
Packing: | Fiber Carton | Shelf Life: | 2 Years |
Moq: | 1kg | Whatsapp: | +8615512123605 |
Wickr: | Wanjiang | ||
High Light: | Male Sex Steroid Hormone Powder Tadalafil,171596-29-5 Steroid Hormone Powder |
Product Name: |
Talafil whatsapp +8615512123605
signal +66980528100
|
Synonyms: | TADAFIL;;IC 351;(6R,12AR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido;GF 196960;ICOS 351;Tildenafil;UK 336017 |
CAS: | 171596-29-5 |
MF: | C22H19N3O4 |
MW: | 389.4 |
EINECS: | 687-782-2 |
Mol File: |
Melting point | 298-300°C |
alpha | D20 +71.0° |
Boiling point | 679.1±55.0 °C(Predicted) |
density | 1.51±0.1 g/cm3(Predicted) |
Fp | 2℃ |
storage temp. | Sealed in dry,2-8°C |
solubility | DMSO: soluble20mg/mL, clear |
pka | 16.68±0.40(Predicted) |
form | powder |
color | white to beige |
optical activity | [α]/D +68 to +78°, c = 1 in chloroform-d |
InChIKey | WOXKDUGGOYFFRN-IIBYNOLFSA-N |
CAS DataBase Reference | 171596-29-5 |
Description:
Tadlfil (Tadalifil citrate), a phosphodiesterase type 5 inhibitor, is used to treat erectile dysfunction (ED) and decreased libido in males. works by aiding relaxation of blood vessels and increasing blood flow in the during arousal, resulting in improved erectile function. much longer lasting. Effects can be felt anywhere between 36-48 hours.
Action: Tadafil improves erectile function significantly, possibly increased activity, and is very safe.
There are limited side effects associated with its use. The most common side effects are headache, upset stomach, back pain, and muscle aches, and usually subside with in a few hours.
Tadalil was also found to be significantly higher at the end of the month, due to increased activity.
Applications:
Tadafil is a PDE5 inhibitor marketed in pill form for treating erectile dysfunction (ED) under the name Tadafil, and under the name Adcirca for the treatment of pulmonary arterial hypertension.
Tadafil's pharmacologic distinction is its longer half-life (17.50 hours) resulting in longer duration of action, and so partly responsible for "The Weekend Pill" sobriquet. Furthermore, the longer half-life is the basis for current investigation daily therapeutic use in relieving pulmonary arterial hypertension.
Specifications:
Test Items | Specification | Test Results |
Appearance | White powder | Conforms |
Test method | High pressure liquid chromatography(HPLC) | Conforms |
Melting Point | 300℃~303℃ | 301.5℃-302.6℃ |
Loss on drying | ≤0.5% | 0.24% |
Heavy metals(Pb) | ≤20ppm | 7.5ppm |
Residue on ignition | ≤0.1% | 0.08% |
Relative substance | ≤1.0% | 0.145% |
Assay (on dried basis) | ≥98.5% | 99.33% |
Conclusion | The product conform to USP 32. |
Contact Person: Michelle fiona
Tel: +8615512123605